| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Special Feature |
Division of Endocrinology (O.K., M.S.L., R.B., I.K., E.M.B.), Diabetes and Hypertension, and Membrane Biology Program, and Department of Surgery (F.D.M.), Brigham and Womens Hospital, and Harvard Medical School (O.K., M.S.L., R.B., I.K., E.M.B., F.D.M.), Boston, Massachusetts 02115; Department of Endocrinology (A.M.), Royal North Shore Hospital, Sydney, Australia 2065; and Scantibodies Laboratories (P.G., T.L.C.), Santee, California 92071-2861
Address all correspondence and requests for reprints to: Edward M. Brown, M.D., Endocrine-Hypertension Division, Department of Medicine, Brigham and Womens Hospital, 221 Longwood Avenue, Boston, Massachusetts 02115. E-mail: embrown{at}rics.bwh.harvard.edu.
Autoimmune hypoparathyroidism is thought to result from immune-mediated destruction of the parathyroid glands. We encountered two patients with hypoparathyroidism and other autoimmune conditions (Graves disease and Addisons disease, respectively) in whom autoimmune destruction of the parathyroid glands had not taken place. In the first, a histologically normal parathyroid gland was observed at the time of subtotal thyroidectomy; and in the second, the hypoparathyroidism remitted spontaneously. Both patients had antibodies that reacted with the cell surface of bovine parathyroid cells and human embryonic kidney (HEK293) cells transfected with the extracellular calcium-sensing receptor (CaR) but not with nontransfected HEK293 cells. The antibodies also reacted with the same bands on Western analysis of extracts of bovine parathyroid tissue and CaR-transfected HEK293 cells that were identified by an authentic, polyclonal, anti-CaR antiserum and reacted with several peptides with sequences from the CaRs extracellular domain. These anti-CaR antibodies activated the receptor based on their ability to increase inositol phosphate accumulation, activate MAPK, and inhibit PTH secretion. These results, therefore, demonstrate that patients with the biochemical findings of primary hypoparathyroidism can harbor activating antibodies to the CaR, which, in the two cases studied here, did not produce irreversible destruction of the parathyroid glands.
This work was supported by the NIH (DK41415, DK48330, and DK52005) and The St. Giles Foundation.
Abbreviations: APS, Autoimmune polyendocrinopathy syndrome; Ca2+i, cytosolic calcium concentration; Ca2+o, extracellular calcium; CaR, calcium-sensing receptor; GF, glomerular filtrate; GFR, glomerular filtration rate; nl., normal; pERK, phospho-ERK; SDS, sodium dodecyl sulfate.
This article has been cited by other articles:
![]() |
D. Shoback Hypoparathyroidism N. Engl. J. Med., July 24, 2008; 359(4): 391 - 403. [Full Text] [PDF] |
||||
![]() |
N. G. Gavalas, E. H. Kemp, K. J. E. Krohn, E. M. Brown, P. F. Watson, and A. P. Weetman The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2107 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huang, A. Sindic, C. E. Hill, K. M. Hujer, K. W. Chan, M. Sassen, Z. Wu, Y. Kurachi, S. Nielsen, M. F. Romero, et al. Interaction of the Ca2+-sensing receptor with the inwardly rectifying potassium channels Kir4.1 and Kir4.2 results in inhibition of channel function Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1073 - F1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mayer, C. Ploix, J. Orgiazzi, A. Desbos, A. Moreira, H. Vidal, J.-C. Monier, J. Bienvenu, and N. Fabien Calcium-Sensing Receptor Autoantibodies Are Relevant Markers of Acquired Hypoparathyroidism J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4484 - 4488. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Stewart Translational Implications of the Parathyroid Calcium Receptor N. Engl. J. Med., July 22, 2004; 351(4): 324 - 326. [Full Text] [PDF] |
||||
![]() |
S. H. S. Pearce and N. J. Leech Toward Precise Forecasting of Autoimmune Endocrinopathy J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 544 - 547. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |